Hydrocortisone Sodium Succinate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Hydrocortisone Sodium Succinate Injection (injection) from Cipla Limited with status No longer listed by FDA. The shortage was first posted on Mar 24, 2023.
Shortage details
- Status
- No longer listed by FDA
- Company
- Cipla Limited
- Package NDC
- 69097-004-67
- Dosage Form
- Injection
- Presentation
- Hydrocortisone Sodium Succinate, Injection, 100 mg/ Vial (NDC 69097-004-67)
- Initial Posting
- Mar 24, 2023